2000-2019年美国妊娠合并丙型肝炎病毒感染患者的分娩情况
孕期HCV诊断患病率从2000年0.05%升至2019年0.49%,年均百分比变化12.5%(95% CI 10.4-14.8%)。调整后HCV感染与严重孕产妇发病率(aOR 1.78)、早产(aOR 1.88)和剖宫产(aOR 1.27)风险增加相关。
要点
- 孕期HCV诊断患病率从2000年0.05%升至2019年0.49%,年均百分比变化12.5%(95% CI 10.4-14.8%)。
- HCV感染与严重孕产妇发病率(aOR 1.78,95% CI 1.61-1.96)、早产(aOR 1.88,95% CI 1.8-1.95)和剖宫产(aOR 1.27,95% CI 1.23-1.31)风险增加相关。
- 与HCV感染相关的临床特征(阿片类药物使用障碍、非阿片类物质使用障碍、精神健康状况、烟草使用)患病率同期均上升。
核心结论
- 孕期HCV诊断在产科人群中日益常见,可能反映筛查增加或真实患病率上升。
- HCV感染诊断的增加发生在许多与HCV感染相关的基线临床特征变得更加常见的背景下。
研究设计与样本
- 横断面研究,分析美国全国住院患者样本中分娩住院数据。
- 使用joinpoint回归估计年均百分比变化(AAPC)及95% CI,使用调查调整logistic回归模型评估HCV感染与早产、剖宫产和严重孕产妇发病率(SMM)的关联,报告调整比值比(aOR)。
主要发现
- 孕期HCV诊断患病率从2000年0.05%升至2019年0.49%,AAPC为12.5%(95% CI 10.4-14.8%)。
- 与HCV感染相关的临床特征患病率上升:阿片类药物使用障碍从10例/10,000例分娩住院升至71例/10,000例分娩住院;非阿片类物质使用障碍从71例/10,000例分娩住院升至217例/10,000例分娩住院;精神健康状况从219例/10,000例分娩住院升至1,117例/10,000例分娩住院;烟草使用从61例/10,000例分娩住院升至842例/10,000例分娩住院。
- 具有两种或以上与HCV感染相关临床特征的患者分娩率从26例/10,000例分娩住院升至377例/10,000例分娩住院(AAPC 13.4%,95% CI 12.1-14.8%)。
- 调整分析中,HCV感染与SMM风险增加相关(aOR 1.78,95% CI 1.61-1.96)。
- 调整分析中,HCV感染与早产风险增加相关(aOR 1.88,95% CI 1.8-1.95),与剖宫产风险增加相关(aOR 1.27,95% CI 1.23-1.31)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess clinical characteristics, trends, and outcomes associated with the diagnosis of hepatitis C virus (HCV) infection during pregnancy. METHODS: This cross-sectional study analyzed delivery hospitalizations using the National Inpatient Sample. Temporal trends in both diagnosis of HCV infection and clinical characteristics associated with HCV infection were analyzed using joinpoint regression to estimate the average annual percent change (AAPC) with 95% CIs. Survey-adjusted logistic regression models were fit to assess the association among HCV infection and preterm delivery, cesarean delivery, and severe maternal morbidity (SMM), adjusting for clinical, medical, and hospital factors with adjusted odds ratios (aORs) as the measure of association. RESULTS: An estimated 76.7 million delivery hospitalizations were included, in which 182,904 (0.24%) delivering individuals had a diagnosis of HCV infection. The prevalence of HCV infection diagnosed in pregnancy increased nearly 10-fold over the study period, from 0.05% in 2000 to 0.49% in 2019, representing an AAPC of 12.5% (95% CI 10.4-14.8%). The prevalence of clinical characteristics associated with HCV infection also increased over the study period, including opioid use disorder (from 10 cases/10,000 birth hospitalizations to 71 cases/10,000 birth hospitalizations), nonopioid substance use disorder (from 71 cases/10,000 birth hospitalizations to 217 cases/10,000 birth hospitalizations), mental health conditions (from 219 cases/10,000 birth hospitalizations to 1,117 cases/10,000), and tobacco use (from 61 cases/10,000 birth hospitalizations to 842 cases/10,000). The rate of deliveries among patients with two or more clinical characteristics associated with HCV infection increased from 26 cases per 10,000 birth hospitalizations to 377 cases per 10,000 delivery hospitalizations (AAPC 13.4%, 95% CI 12.1-14.8%). In adjusted analyses, HCV infection was associated with increased risk for SMM (aOR 1.78, 95% CI 1.61-1.96), preterm birth (aOR 1.88, 95% CI 1.8-1.95), and cesarean delivery (aOR 1.27, 95% CI 1.23-1.31). CONCLUSION: Diagnosis of HCV infection is increasingly common in the obstetric population, which may reflect an increase in screening or a true increase in prevalence. The increase in HCV infection diagnoses occurred in the setting of many baseline clinical characteristics that are associated with HCV infection becoming more common.
引用
- Arditi B, Emont J, Friedman AM, et al. Deliveries Among Patients With Maternal Hepatitis C Virus Infection in the United States, 2000-2019. Obstet Gynecol. 2023. PMID: 36897136. doi:10.1097/AOG.0000000000005119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。